Rubicon Research Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Rubicon Research Limited's yearly results, compared with Healthcare companies in India. Tap ? on any ratio for what it means.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
1.8×Debt due within a year is covered 1.8 times by its yearly operating cash.
Higher than 58% of Healthcare companies in India.
Cash Cushion Ratio
+0%Cash, after subtracting all debt, equals 0% of its market value (net cash).
Higher than 60% of Healthcare companies in India.
Tangible Assets Ratio
97%Of every ₹100 the company owns, ₹97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 50% of Healthcare companies in India.
Tangible Net Worth Ratio
95%Of every ₹100 of net worth, ₹95 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 51% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Rubicon Research Limited owes ₹0.45 for every ₹1 it owns.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
82.1Investors pay ₹82.1 for every ₹1 of Rubicon Research Limited's yearly profit, higher than 87% of Healthcare companies in India.
P/B ratio
18.30The share price is 18.30 times Rubicon Research Limited's book value per share, higher than 97% of Healthcare companies in India.
Market cap
₹23,579 CrThe total market value of all of Rubicon Research Limited's shares at today's price (share price × number of shares), larger than 79% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹1,289 CrWhat Rubicon Research Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹77.86Net worth divided by the number of shares. The share price of ₹1,424 is 18.3 times this, which is the P/B above.
Return on equity (ROE)
22.2%Rubicon Research Limited earned 22.2% on its shareholders' money over the last year, higher than 86% of Healthcare companies in India.
Owes vs Owns
0.45×Rubicon Research Limited owes ₹0.45 for every ₹1 it owns (low), higher than 70% of Healthcare companies in India.
Dividend yield
0.10%Rubicon Research Limited pays 0.10% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in India.
Revenue growth
+37%Revenue rose 37% in the year to Mar 2026.
Profit margin
14.3%Rubicon Research Limited keeps ₹14 of every ₹100 of revenue as net profit.
Cash quality
0.8×Cash from Rubicon Research Limited's business was 0.8× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
11.5×Rubicon Research Limited's operating profit covered its interest costs 11.5 times in the year to Mar 2026.
Cash vs debt
Net cashRubicon Research Limited held ₹25 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Rubicon Research Limited's P/E ratio?
Investors pay ₹82.1 for every ₹1 of Rubicon Research Limited's yearly profit, higher than 87% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Rubicon Research Limited: ₹23,579 Cr ÷ ₹1,289 Cr (31 Mar 2026) = 18.3.
What is Rubicon Research Limited's return on equity?
Rubicon Research Limited earned 22.2% on its shareholders' money over the last year, higher than 86% of Healthcare companies in India.
How much does Rubicon Research Limited owe compared with what it owns?
Rubicon Research Limited owes ₹0.45 for every ₹1 it owns (low), higher than 70% of Healthcare companies in India.
Does Rubicon Research Limited pay a dividend?
Yes. Rubicon Research Limited pays 0.10% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in India.
Is Rubicon Research Limited's revenue growing?
Revenue rose 37% in the year to Mar 2026.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.